In the United States and elsewhere, there’s been a major shift in patients treated for lung cancer. As the percentage of ...

Applicants to a prestigious National Science Foundation fellowship program say many submissions have been mysteriously ...

The director-general of the WHO said a U.S.-funded study of the hepatitis B vaccine in Guinea-Bissau would be “unethical” if ...

The rejection is the latest instance of Vinay Prasad overruling career FDA scientists to place vaccines under harsher ...

To reduce heart disease risk, it's the quality, not the quantity, of carbs or fats that matter, says new study from the ...

You’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence ...

So: Moderna says it was blindsided by the FDA, and Vinay Prasad, on its mRNA flu vaccine. Meanwhile, regulators are moving ...

The Trump administration wants the 2027 ACA marketplace to offer plans with lower premiums — but the tradeoff is high deductibles and risk for those needing care.

The country’s second largest Medicare Advantage insurer had to dramatically scale back its offerings last year after it sold generous plans that attracted sicker-than-expected members. Going into 2026 ...

As President Trump hails pricing agreements with the pharmaceutical industry, some biotech companies are worried they have been left out in the cold.

Solitary reflection is essential to clinical work, but it can also quietly narrow the range of perspectives a therapist ...

The head of biomedical research at Novartis spoke with STAT about AI, pruning the pipeline, and a potential blockbuster.